FMR LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 87 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$10,037,888
-18.7%
6,691,925
-13.8%
0.00%0.0%
Q2 2023$12,340,454
+10.7%
7,761,292
-50.1%
0.00%0.0%
Q1 2023$11,148,144
+147.5%
15,539,648
+99.9%
0.00%
Q4 2022$4,504,380
-56.4%
7,772,874
-28.5%
0.00%
-100.0%
Q3 2022$10,325,000
-20.8%
10,868,650
-0.0%
0.00%0.0%
Q2 2022$13,043,000
-8.4%
10,869,270
-0.0%
0.00%0.0%
Q1 2022$14,245,000
+712150.0%
10,873,853
+929289.1%
0.00%
Q4 2021$2,000
-33.3%
1,1700.0%0.00%
Q3 2021$3,000
-25.0%
1,1700.0%0.00%
Q2 2021$4,000
-99.9%
1,170
-99.8%
0.00%
-100.0%
Q1 2021$7,636,000
-9.0%
774,4420.0%0.00%0.0%
Q4 2020$8,395,000
+5.2%
774,4420.0%0.00%0.0%
Q3 2020$7,977,000
+29.0%
774,442
+161.5%
0.00%0.0%
Q2 2020$6,183,000
+261.6%
296,142
+69.2%
0.00%
Q1 2020$1,710,000
-61.8%
175,008
-76.4%
0.00%
-100.0%
Q3 2018$4,482,000
-21.5%
740,815
-31.2%
0.00%0.0%
Q2 2018$5,711,000
-0.9%
1,077,502
+8.5%
0.00%0.0%
Q1 2018$5,761,000
+199.3%
993,283
+80.6%
0.00%
Q4 2017$1,925,000
-66.5%
550,086
-65.0%
0.00%
-100.0%
Q3 2017$5,739,000
+27.0%
1,572,286
-13.0%
0.00%0.0%
Q2 2017$4,520,000
-39.6%
1,808,089
-34.7%
0.00%0.0%
Q1 2017$7,480,000
-30.4%
2,770,550
-25.2%
0.00%0.0%
Q4 2016$10,749,000
-30.7%
3,706,402
-1.8%
0.00%
-50.0%
Q3 2016$15,515,000
+27.0%
3,774,845
-2.3%
0.00%0.0%
Q2 2016$12,214,0003,865,1530.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 420,000$1,134,0000.67%
EcoR1 Capital, LLC 874,447$2,361,0000.60%
VHCP Management II, LLC 280,000$756,0000.31%
683 Capital Management, LLC 350,000$945,0000.15%
AWM Investment Company, Inc. 400,000$1,080,0000.10%
JW Asset Management, LLC 178,654$482,0000.10%
TFS CAPITAL LLC 89,156$241,0000.08%
Rhenman & Partners Asset Management AB 154,006$416,0000.07%
SABBY MANAGEMENT, LLC 282,630$763,0000.04%
Numeric Investors LLC 1,087,967$2,938,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders